Label for a vial
Latest Genentech, Inc. Patents:
- Pharmaceutical compositions comprising Akt protein kinase inhibitors
- PREVENTION OF DISULFIDE BOND REDUCTION DURING RECOMBINANT PRODUCTION OF POLYPEPTIDES
- Inhibitors of IAP
- Three-dimensional object segmentation of medical images localized with object detection
- SERVICE TO SERVICE COMMUNICATION AND AUTHENTICATION VIA A CENTRAL NETWORK MESH
The dash-dash broken lines illustrate portions of the label for the vial or environment that form no part of the claimed design.
The dash-dash broken lines illustrate portions of the label for a vial or environment that form no part of the claimed design.
Claims
The ornamental design for a label for a vial, as shown and described.
1987418 | January 1935 | Plishker |
3212214 | October 1965 | Patterson |
3273781 | September 1966 | Mills |
4048737 | September 20, 1977 | McDermott |
D275177 | August 21, 1984 | Villanueva |
5135125 | August 4, 1992 | Andel et al. |
5490658 | February 13, 1996 | Coward et al. |
5732491 | March 31, 1998 | Burtch |
5823503 | October 20, 1998 | Wasserman |
6110553 | August 29, 2000 | Grosskopf et al. |
D443894 | June 19, 2001 | Schwartz |
6546656 | April 15, 2003 | Twentier |
D596240 | July 14, 2009 | Muniz |
D613451 | April 6, 2010 | Welsh |
D676490 | February 19, 2013 | Bratter |
D676572 | February 19, 2013 | Tarriff |
D702765 | April 15, 2014 | Williams |
D729313 | May 12, 2015 | Glass |
D741955 | October 27, 2015 | Clark |
D752682 | March 29, 2016 | Sato |
D785710 | May 2, 2017 | Lin |
D785711 | May 2, 2017 | Lin |
D786976 | May 16, 2017 | Keating |
D860322 | September 17, 2019 | Edwards |
D888828 | June 30, 2020 | Dittrich |
D892212 | August 4, 2020 | Sato |
20020073587 | June 20, 2002 | Twentier |
20040104274 | June 3, 2004 | Kotik |
20070014958 | January 18, 2007 | Chaplin et al. |
102004046552 | April 2006 | DE |
102012015557 | February 2014 | DE |
2695824 | February 2014 | EP |
D129022 | June 2009 | TW |
D140218 | April 2011 | TW |
- Albumin (Human) 25% Solution AlbuRx ®25, CSL Behring, located at <http://www.fffenterprises.com/assets/downloads/pi-Albumin-PPF_ALBURX%2025_CSL%20Behring.pdf> last visited Jan. 7, 2021, 2 pages.
- Alburx 25% 100ml CSL, prescribing details, located at <https://biosupply.fffenterprises.com/alburx-25-100ml-esl-5.html#> last visited Jan. 7, 2021, 3 pages.
- Goldberg, C. (Dec. 18, 2017). “Mass General Hospital Raises Red Flag About National Shortage of IV Fluids,” CommonHealth, located at <https://www.wbur.org/commonhealth/2017/12/18/mass-general-hospital-iv-fluids> last visited Jan. 7, 2021, 7 pages.
- NDC 44206-310 Alburx, Albumin (human) description, located at <https://ndclist.com/ndc/44206-310#description> last visited Jan. 7, 2021, 7 pages.
Type: Grant
Filed: Jan 27, 2020
Date of Patent: Sep 21, 2021
Assignee: Genentech, Inc. (South San Francisco, CA)
Inventors: Mahesh Khurana (San Bruno, CA), Dominique Daniel Schall (Lörrach), Kai Zheng (Foster City, CA), Erin Susan Araj (Pleasanton, CA)
Primary Examiner: Mary Ann Calabrese
Assistant Examiner: Catherine Ho
Application Number: 29/722,202